Table of Contents
Thrombosis
Volume 2011, Article ID 981497, 4 pages
http://dx.doi.org/10.1155/2011/981497
Clinical Study

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children

1Department of Clinical Haematology, Centre for Thrombosis and Haemostasis. Children's University Hospital, Masaryk University, 62500 Brno, Czech Republic
2Institute of Biostatistics and Analyses, Masaryk University, 62500 Brno, Czech Republic

Received 21 July 2010; Revised 14 January 2011; Accepted 12 February 2011

Academic Editor: Domenico Prisco

Copyright © 2011 Veronika Fiamoli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Hirsh, “Drug therapy: heparin,” The New England Journal of Medicine, vol. 324, no. 22, pp. 1565–1574, 1991. View at Google Scholar
  2. R. Collins, A. Scrimgeour, S. Yusuf, and R. Peto, “Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery,” The New England Journal of Medicine, vol. 318, no. 18, pp. 1162–1173, 1988. View at Google Scholar · View at Scopus
  3. G. P. Clagett and J. S. Reisch, “Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis,” Annals of Surgery, vol. 208, no. 2, pp. 227–240, 1988. View at Google Scholar · View at Scopus
  4. G. Castaman, F. Rodeghiero, and E. Dini, “Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia,” Haematologica, vol. 75, no. 6, pp. 567–569, 1990. View at Google Scholar · View at Scopus
  5. D. Bernstein, S. Coupey, and S. K. Schoenberg, “Pulmonary embolism in adolescents,” American Journal of Diseases of Children, vol. 140, no. 7, pp. 667–671, 1986. View at Google Scholar · View at Scopus
  6. M. Andrew, M. David, M. Adams et al., “Venous thromboembolic complications (VTE) in children: first analyses of the Canadian registry of VTE,” Blood, vol. 83, no. 5, pp. 1251–1257, 1994. View at Google Scholar · View at Scopus
  7. P. Monagle, M. Adams, M. Mahoney et al., “Outcome of pediatric thromboembolic disease: a report from the Canadian childhood thrombophilia registry,” Pediatric Research, vol. 47, no. 6, pp. 763–766, 2000. View at Google Scholar · View at Scopus
  8. J. Yang, N. Paredes, and A. K. C. Chan, “Antithrombotic therapy in children with venous thromboembolism,” Hamostaseologie, vol. 29, no. 1, pp. 80–87, 2009. View at Google Scholar · View at Scopus
  9. L. T. Vu, K. K. Nobuhara, H. Lee, and D. L. Farmer, “Determination of risk factors for deep venous thrombosis in hospitalized children,” Journal of Pediatric Surgery, vol. 43, no. 6, pp. 1095–1099, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. B. Schmidt and M. Andrew, “Neonatal thrombosis: report of a prospective Canadian and international registry,” Pediatrics, vol. 96, no. 5 I, pp. 939–943, 1995. View at Google Scholar · View at Scopus
  11. M. David and M. Andrew, “Venous thromboembolism complications in children: a critical review of the literature,” Journal of Pediatrics, vol. 123, pp. 337–346, 1993. View at Google Scholar
  12. B. Schmidt and M. Andrew, “Neonatal thrombosis: report of a prospective Canadian and international registry,” Pediatrics, vol. 96, no. 5 I, pp. 939–943, 1995. View at Google Scholar · View at Scopus
  13. P. Monagle, E. Chalmers, A. Chan et al., “Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition),” Chest, vol. 133, no. 6, pp. 887–968, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. P. Massicotte, J. A. Julian, M. Gent et al., “An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial,” Thrombosis Research, vol. 109, no. 2-3, pp. 85–92, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Blatný and V. Fiamoli, “Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children—an alternative to subcutaneous application when needed,” Vnitrni Lekarství, vol. 55, no. 3, pp. 227–232, 2009. View at Google Scholar · View at Scopus
  16. R. C. Punzalan, C. A. Hillery, R. R. Montgomery, J. P. Scott, and J. C. Gill, “Low-molecular-weight heparin in thrombotic disease in children and adolescents,” Journal of Pediatric Hematology/Oncology, vol. 22, no. 2, pp. 137–142, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Massicotte, M. Adams, V. Marzinotto, L. A. Brooker, and M. Andrew, “Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study,” Journal of Pediatrics, vol. 128, no. 3, pp. 313–318, 1996. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Hoffmann, J. Harenberg, K. Bauer et al., “Bioequivalence of subcutaneous and intravenous body-weight-independent high-dose low-molecular-weight heparin Certoparin on anti-Xa, Heptest, and tissue factor pathway inhibitor activity in volunteers,” Blood Coagulation and Fibrinolysis, vol. 13, no. 4, pp. 289–296, 2002. View at Publisher · View at Google Scholar · View at Scopus